A breast cancer drug known for extending lives will not be routinely available on the NHS because it is too expensive. NICE (National Institute of Health Care and Excellence) has confirmed that Kadcyla, a drug able to extend life expectancy by around six months in patients with incurable breast cancer, will not be available for all suitable candidates in […]